TUCSON, Ariz.--(BUSINESS WIRE)--The Critical Path Institute (C-Path), a Tucson-based nonprofit that works with the FDA and the biomedical industry to streamline the development of crucial new medicines, has been awarded a $9 million investment grant from Science Foundation Arizona (SFAz). These funds will result in better testing methods that accelerate the development of therapies for major diseases, including lung cancer, stroke, Alzheimer’s and Parkinson’s.
